Pediatric Medulloblastoma: Prognostic Value of Preoperative Blood Cell Ratios

Ehsan Alimohammadi; Seyed Reza Bagheri; Atefeh Arast; Homa Hadidi; Roya  Safari-Faramani

doi:10.18502/ijhoscr.v16i3.10135

Ehsan Alimohammadi Department of Neurosurgery, Kermanshah University of Medical Sciences, Imam Reza Hospital, Kermanshah, Iran
Seyed Reza Bagheri Department of Neurosurgery, Kermanshah University of Medical Sciences, Imam Reza Hospital, Kermanshah, Iran
Atefeh Arast Clinical Research Development Center, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran
Homa Hadidi Kermanshah University of Medical Sciences, Imam Reza Hospital, Kermanshah, Iran
Roya Safari-Faramani Research Center for Environmental Determinants of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran

DOI: https://doi.org/10.18502/ijhoscr.v16i3.10135

Keywords: Pediatric medulloblastoma; Progression-free survival; Neutrophil to lymphocyte ratio; Lymphocyte to monocyte ratio

Abstract

Background: The prognostic significance of preoperative neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), and platelet to lymphocyte ratio (PLR) have been demonstrated in various tumors. This study aimed to evaluate the prognostic role of these ratios in pediatric medulloblastoma.

Materials and Methods: Forty-three pediatric patients with medulloblastoma were evaluated, retrospectively. Clinical, radiological, and laboratory data were extracted from the electronic medical records of the patients. Univariate and multivariate Cox proportional hazard models were used to evaluate the impact of suggested variables, including NLR, LMR, and PLR on progression-free survival (PFS) and overall survival (OS). Kaplan-Meier curves were plotted for the assessment of PFS and OS. The Log-rank test was used to assess differences between the PFS and OS in the related categories.

Results: There were 27 males (62.8%) and 16 females (37.2%) with a mean age of 7.4 ±3.3 years. The median OS and PFS were 62.8 ±17.2 and 43.3 ±15.6 months, respectively. The multivariate Cox model showed the clinical risk group, NLR, and LMR as independent predictors of the PFS and the OS (p<0.05). The Log-rank test revealed that OS and PFS were higher in patients with NLR <4 and those with LMR ≥ 3.48 (p <0.05). There were no differences between patients with PLR>200 and PLR< 200 based on OS and PFS.

Conclusion: Our results suggest an elevated preoperative NLR and a lowered preoperative LMR as simple predictors of survival in pediatric medulloblastoma. These cost-effective and easily available ratios, along with previously established variables, could be valuable to predict survival in pediatrics with medulloblastoma.